propylthiouracil 50 mg
INDICATIONS AND USAGE Propylthiouracil is indicated: in patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter who are intolerant of methimazole and for whom surgery or radioactive iodine therapy is not an appropriate treatment option to ameliorate symptoms of hyperthyroidism in preparation for thyroidectomy or radioactive iodine therapy in patients who are intolerant of methimazole
par pharmaceutical, inc.
Related Pills
propylthiouracil tablet
american health packaging
propylthiouracil tablet
american health packaging
propylthiouracil tablet
american health packaging
levothyroxine sodium 38 MCG liothyronine sodium 9 MCG Oral Tablet
acella pharmaceuticals, llc
hydrocortisone 5 MG Oral Tablet
Lineage Therapeutics Inc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
PROPYLTHIOURACIL Tablets, USP, 50 mg, are round, white, scored tablets, engraved P33, supplied as: NDC 67253-651-10 Bottle of 100 NDC 67253-651-11 Bottle of 1000 Store at controlled room temperature 15° to 30°C (59° to 86°F).
More pills like ROUND P 33